創世紀(300083.SZ):公司高端五軸和高端卧加產品的研發已取得了實質進展,實現了批量出貨
格隆匯3月3日丨創世紀(300083.SZ)近日在線上電話會議上表示,公司在橫向豐富產品品類的同時,也積極推動縱深高端化升級,特別是以五軸為代表的高端化產品,公司持續投入研發。
目前,公司高端五軸和高端卧加產品的研發已取得了實質進展,實現了批量出貨,相關產品的質量和服務水平已持續獲得客户認可。
未來,公司繼續加大對高端產品的研發投入和市場開拓,隨着公司高端產品的持續放量,營收佔比的提升,有望帶動公司盈利能力進一步提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.